Sato Pharmaceutical Co., Ltd.
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1939-08-01
- Employees
- 501
- Market Cap
- -
Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis
Phase 1
- Conditions
- Onychomycosis of Toenail
- Interventions
- Drug: SKX-16 (Luliconazole 10% Solution)
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- SATO Pharmaceutical Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT05110638
- Locations
- 🇺🇸
J&S Studies, Inc., College Station, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath